Cumulative incidence of therapy-related neoplasms, other incident cancers, and deaths following first primary solid tumors or lymphoid neoplasms. Cumulative incidence of (A,B) all t-HNs combined (t-MDS/AML, t-CML, t-cMPN, t-CMML, and tr-ALL), other incident cancers (excluding t-HNs), and deaths; (C,D) t-MDS/AML and other t-HNs combined (t-CML, t-cMPN, t-CMML, and tr-ALL); and (E,F) t-CML, t-cMPN, t-CMML, and tr-ALL. Number of individuals at risk at 1, 3, 5, 10, and 15 years with a first primary solid tumor: 1 038 829, 613 755, 428 193, 186 814, and 57 251, respectively; or with a first primary lymphoid neoplasm: 186 503, 129 157, 93 230, 39 532, and 11 910, respectively. Note the change in y-axis between figures.